Compounded vs. FDA-approved: what's the difference?

Approved drugs and compounded prescriptions can both involve a prescriber and a white coat, but they are not the same product pathway. One route ships with a giant FDA packet and fixed specs. The other is built to order under pharmacy law. Mixing the two in your head is how people get surprised by potency swings or enforcement headlines.

What "FDA approved" actually buys you

Approval means a sponsor ran the gauntlet: preclinical work, phased human trials, manufacturing controls, labeling negotiations. It costs years and serious money because the agency wants reproducible batches and a known risk picture for specific indications.

Commercial sites run under GMP expectations with release testing tied to the NDA or BLA. That does not mean every vial is perfect; it means there is a paper trail and an inspection regime behind the failures when they happen.

What compounding is

Compounding is a pharmacist preparing a medication for a named patient from a valid prescription, under 503A storefront rules or 503B outsourcing rules, depending on the setup. It exists because humans are weird sizes with weird allergies and sometimes the factory pill is the wrong shape.

Bulk ingredients have to fit FDA lists, USP monographs, or other allowed hooks. Category 2 bulk substances are off the table for 503A compounding until the list changes. That gate is separate from whether your cousin likes the telehealth brand.

Compounded drugs skip the full approval package for that specific mixture. Trials were run on the commercial drug, not on your pharmacy's bottle. Quality still matters; the scaffolding around it is different, and it varies shop to shop.

Questions worth asking a compounding pharmacy

Ask where the API came from, what release testing they ran on your lot, and whether a sterile product was made under conditions appropriate for injections. Ask who holds the beyond-use date and how they calculated it. If staff get vague, treat that as information.

Why compounding blew up around GLP-1s

Kids need liquids. Adults need dye-free bases. Those are old reasons compounding exists.

Newer fights center on patented GLP-1s: telehealth scripts, lower cash prices, and FDA shortage-list politics in 2025 that yanked a compounding cushion for semaglutide and tirzepatide while lawsuits rolled on. Whether you think that is fair depends on whether you sell branded pens or buy them.

Same ingredient name, different object

Retail Ozempic from Novo Nordisk is the approved chain: fixed formulation, inspected plants, patient-facing label written off trials. Compounded semaglutide from a 503A shop is a custom preparation using a salt form, excipients, and release testing chosen by that site. Same letters on a chart, different object.

Approved is not magic; compounded is not automatically shady. They trade off convenience, price, paperwork, and how much uncertainty you are willing to own. Pick based on facts from your clinician and pharmacy, not on which word sounds cleaner in a tweet.